Highlights of the financial year 2018
Sales
+3.1%
Currency-adjusted sales growth in 2018
Sales development
2009 – 2018
2009 – 2018
(in CHF million)
EBIT, EBITDA, Net income,
Earnings per share (EPS)
2016 – 2018
Earnings per share (EPS)
2016 – 2018
(in CHF million)
(EPS: in CHF)
* Adjusted for costs in connection with the Sanitec acquisition and integration
(EBITDA 2018 not adjusted)
Net income development
2009 – 2018
2009 – 2018
(in CHF million)
* Adjusted for costs in connection with the Sanitec acquisition and integration
Free cashflow
(in CHF)
582 million
+22.2% versus prior year
Operating cashflow margin
(EBITDA margin)
(EBITDA margin)
28.2%
Around previous year's performance
Payout ratio
62.7%
The payout ratio is in the upper range of the target corridor of 50 to 70%
Adjusted earnings per share
(in CHF)
(in CHF)
17.21
+4.7% versus prior year
R&D expenditures
(in CHF)
78 million
Around previous year's performance
Investments in property, plant and equipment and intangible assets
(in CHF)
(in CHF)
162 million
+1.9% versus prior year
Currency effects in sales
(in CHF)
+83 million
Currency effects in EBIT
(in CHF)
(in CHF)